Navigation Links
University of Nevada, Reno research team discovers hormone that causes malaria mosquito to urinate

Discovery has implications for control of mosquitoes, malaria and West Nile Virus

Prior to coming to Nevada 16 years ago, David Schooley was a key figure at a small company in Palo Alto, Calif. that developed methoprene, an insecticide that halts the maturation of insect larvae to adults.

Methoprene, which has the same effect as an insect hormone called juvenile hormone, also stops the insect from reproducing. It is being used heavily throughout the United States to help prevent the spread of West Nile Virus.

Schooley's contribution to the development of methoprene was to prove that it is harmless to animals and the environment.

"Table salt is far more toxic," said Schooley, a professor of biochemistry at the University of Nevada, Reno's College of Agriculture, Biotechnology and Natural Resources

The problem with methoprene, however, is that for a species such as the tobacco hornworm, methoprene causes it to grow larger instead of transforming into a moth, enhancing the pest's ability to devastate crops.

"It's not a great way to sell an insecticide to a farmer," Schooley said. "Most money in pesticide development is in making insecticides for pests which attack crops."

This is what lead Schooley, and his colleague Geoff Coast of the University of London, down the path of finding a way to control insects that are pests at the larval stage, a path that has them instead potentially paving the way for better mosquito control.

A potential solution to the problem of killing insects at any stage of development may be found in peptide hormones, small proteins in all animals that regulate most bodily functions. While researching the genome of the malaria mosquito, Schooley discovered two different types of diuretic hormones similar to those from other insect species. These were synthesized at the University of Nevada, Reno then sent to London to study their effects on mosquitoes.

When a mosquito sucks blood from a human--and only pregnant female mosquitoes do this--it will take in twice its body weight in blood. To decrease this added weight, the mosquito urinates on its victim to release fluids.

Coast discovered that introducing one of the two diuretic hormones, DH31, into the mosquito causes the mosquito to excrete fluid rich in sodium chloride, the main salt in blood.

"Only DH31 causes the massive loss of sodium chloride which causes the mosquito to pee," Schooley said. "Stimulation of this process when the mosquito is not feeding could make the mosquito die."

Implications of this discovery, which is published in September's issue of the Journal of Experimental Biology, could lead to the development of a pesticide for controlling mosquitoes.

"Synthetic compounds that mimic the action of these peptide hormones should be useful as pesticides," Schooley said. "Like methoprene, DH31 only affects lower species such as insects, which suggests it should be very safe to non-insect species."

Schooley said that discovery, development and extensive environmental testing of such a pesticide could take up to 10 years, however.


'"/>

Source:University of Nevada College of Agriculture, Biotechnology, and Natural Resources


Related biology news :

1. University of Manchester makes made-to-measure skin and bones a reality using inkjet printers
2. New protein discovered by Hebrew University researchers
3. Next Generation Body Scanner Launched By The University Of Manchester
4. Roundup®highly lethal to amphibians, finds University of Pittsburgh researcher
5. Green catalyst destroys pesticides and munitions toxins, finds Carnegie Mellon University
6. Carnegie Mellon University research reveals how cells process large genes
7. University of Delaware researchers develop cancer nanobomb
8. University of Arizona plant scientists to unravel maize genome
9. Team led by Carnegie Mellon University scientist finds first evidence of a living memory trace
10. University of Utah to help build bionic arm
11. New University of Toronto research a pore excuse for engineering
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/27/2016)... Jan. 27, 2016  Rite Track, Inc. a leading ... West Chester, Ohio announced today the ... staff, based in Austin, Texas , ... to provide modifications, installations and technical support offerings for ... of PLUS, commented, "PLUS has provided world class service ...
(Date:1/22/2016)... 2016 http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ... the  "Global Behavioral Biometric Market 2016-2020" ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the ... Market 2016-2020"  report to their offering. ... http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced the addition ...
(Date:1/20/2016)... , Jan. 20, 2016 A market ... to directly benefit from the explosion in genomics knowledge. ... Howe Sound Research. A range of dynamic trends are ... - personalized medicine - pharmacogenomics - pathogen evolution ... with large markets - greater understanding of the role ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... Francisco, CA (PRWEB) , ... February 04, 2016 ... ... of enterprise talent development and compliance training, today announced an interactive FDA ... Morf Playbook™. The RAPS (Regulatory Affairs Professional Society) accredited interactive course on ...
(Date:2/4/2016)... Feb. 4, 2016 Beike Biotechnology, the ... institutions attended a ceremony in late 2015 to mark ... therapy in 2016. --> ... Platform for Personalized Cell Therapy" was hosted by the ... Center, both subsidiaries of Beike Biotechnology Co., Ltd. ...
(Date:2/4/2016)... BETHESDA, Md. , Feb. 4, 2016  Spherix ... committed to the fostering and monetization of intellectual property, ... VTech and Uniden in the Northern District of ... are moving forward.  Inter Partes ... the U.S. Patent Office.  The IPR was initiated on ...
(Date:2/3/2016)... 3, 2016   ViaCyte, Inc ., a ... pluripotent stem cell-derived islet replacement therapy for the ... today announced that ViaCyte and Janssen Biotech, Inc., ... & Johnson, have agreed to consolidate the assets ... agreement provides ViaCyte with an exclusive license to ...
Breaking Biology Technology: